Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Biochem. 2014 Sep;47(13-14):1195-202. doi: 10.1016/j.clinbiochem.2014.05.066. Epub 2014 Jun 6.

Recent advances in head and neck squamous cell carcinoma--a review.

Author information

  • 1Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Advanced Medical Science Technologies, Golestan University of Medical Sciences, Gorgan, Iran. Electronic address: Safdari_14@yahoo.com.
  • 2Pharmaceutical Science Research Center, School of Pharmacy, Mazandaran University of Medical Science, Sari, Iran.
  • 3Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • 4Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.
  • 5Faculty of Advanced Medical Science Technologies, Golestan University of Medical Sciences, Gorgan, Iran.
  • 6Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Abstract

The current review presents the results of the most recent studies performed on different aspects of human head and neck squamous cell carcinoma, including radiosensitivity induction, efficiency improvement of monoclonal antibodies using low-intensity ultrasound, chemical compounds such as toll-like receptor (TLC) agonists, dasatinib, resveratrol and niclosamide, nuclear inhibition of cancer using STAT3 decoy oligonucleotide, efficiency of anti-EGFR monoclonal antibodies in detection of head and neck cancers and other related issues.

Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

KEYWORDS:

Apoptosis; Cetuximab; EGFR; Erlotinib; Head and neck cancer; Radiosensitivity

PMID:
24912050
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk